Healthcare
Otsuka Holdings Co., Ltd.(OTSKF)
Live Price
Offline$64.10
+0.00% today
1Y Change
+33.33%
Window
Jun 26, 2025 β Jun 24, 2026
- Market Cap
- $5.92T
- Revenue Growth
- +6.1%
- EPS Growth
- +8.2%
- Dividend Yield
- 1.2%
Coverage: 249 bars Β· Jun 26, 2025 β Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Otsuka Holdings Co., Ltd. (OTSKF) is a Healthcare stock with a market cap of $5.92T and listed on OTC. The stock last traded around $64.10 and up 33.3% across the available one-year price window (Jun 26, 2025 β Jun 24, 2026). Baseline metrics include revenue growth of +6.1%, EPS growth of +8.2%, a dividend yield of 1.2%. What stands out right now is revenue +6.1%, EPS +8.2%, free cash flow +40.3% with operating margin 16.0% and ROIC 8.9%. The dividend is present but secondary, with a yield around 1.2%. Valuation is more restrained than many high-expectation growth names at P/E 15.7 and price/sales 2.4. Stock Foundry combines OTSKF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+6.1% vs +7.6% peer median
Operating Margin
Below sector median
+16.0% vs +19.4% peer median
P/E
Below sector median
15.7 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 28, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +6.1% and EPS at +8.2%, with operating margin around 16.0%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.2%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +4.8% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 28, 2026 | β | +0.0% | +0.0% | +0.0% |
2026 Feb 13, 2026 | +66.2% | +14.3% | +14.3% | +14.5% |
2025 Jul 31, 2025 | +11.5% | +0.0% | +0.0% | +0.0% |
Benchmark Edge
OTSKF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
OTSKF
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
OTSKF Max Drawdown
-12.48%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for OTSKF and SPY.
Company Overview
Otsuka Holdings Co., Ltd.
Other OTC
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides BODYMAINTΓ Jelly, a conditioning food product; BODYMAINTΓ Drink, a conditioning beverage; EQUELLE and EQUELLE GelΓ©e, which supports women's health and beauty; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; and OS-1, an oral rehydration solution. In addition, the company offers soft drinks, food products, and wines; clinical testing and medical equipment; cosmetics; warehousing and transport services; chemical products; travel agency services; analysis and measurement equipment; pharmaceutical intermediates; testing equipment, such as vehicle headlight testers; synthetic resin molded products; venture capital services; paper products; artificial turf; ceramic boards, ceramic board masterpiece arts, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; IT solution services; insecticides and toiletry products; and flaky titanate and special compounds. Further, it provides infusion and clinical nutrition products; Xenotransplantation products; hydrazine; plant-based food products, including cheese alternatives, dressings, and desserts; stable isotopes; software and services to enhance management of mental healthcare systems; products for urinary tract health; potassium titanate; bio-pesticides; functional and dietetic foods; spring and mineral water; industrial chemicals; polyolefin foams; anticancer drugs; and adhesive tapes. Additionally, the company operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.
- Leadership
- Makoto Inoue
- IPO Date
- Aug 3, 2012
- Employees
- 35.3k
- Street Address
- 2-9 Kanda-Tsukasamachi
- Mailing
- Tokyo, 101-0048
- Region
- Tokyo, JP
- Reporting Currency
- USD
- Investor Line
- 81 3 6717 1410
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 15.7
- EV/EBITDA
- 9.7
- Price/Sales
- 2.4
- Price/Book
- 1.9
Growth
- Revenue
- +6.1%
- EPS
- +8.2%
- Free Cash Flow
- +40.3%
Profitability
- Gross Margin
- 71.5%
- Operating Margin
- 16.0%
- Net Margin
- 15.0%
- ROE
- 12.8%
- ROIC
- 8.9%
Balance Sheet
- Debt/Equity
- 0.06
- Current Ratio
- 2.33
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.